Robert Park Sells 4,895 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) CFO Robert Park sold 4,895 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total value of $277,448.60. Following the transaction, the chief financial officer owned 81,490 shares of the company’s stock, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Dolby Laboratories Trading Down 1.0%

DLB opened at $54.24 on Friday. The firm has a market cap of $5.13 billion, a P/E ratio of 21.44 and a beta of 0.86. Dolby Laboratories has a 12 month low of $53.45 and a 12 month high of $77.59. The stock has a 50-day moving average of $61.11 and a 200 day moving average of $63.78.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping the consensus estimate of $1.31 by $0.06. The company had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm’s revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the business posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts forecast that Dolby Laboratories will post 3.22 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be given a $0.36 dividend. The ex-dividend date is Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 56.92%.

Institutional Trading of Dolby Laboratories

Institutional investors have recently added to or reduced their stakes in the company. First Horizon Corp bought a new stake in Dolby Laboratories in the third quarter worth about $25,000. Hantz Financial Services Inc. lifted its stake in Dolby Laboratories by 166.7% in the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the last quarter. Rothschild Investment LLC lifted its stake in Dolby Laboratories by 4,046.7% in the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock worth $45,000 after purchasing an additional 607 shares during the last quarter. Fifth Third Bancorp raised its stake in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of Dolby Laboratories during the third quarter valued at approximately $50,000. Institutional investors own 58.56% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on DLB shares. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, January 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Finally, Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, April 27th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.